EUVIMEDEUVIMED entdecken
Open Access

CPEB3 selectively inhibits α‐synuclein aggregation without modulating TDP ‐43 pathology

Ann Teres Babu, Mufeeda Farhana A, Harsha Varthini Periasamy, Vinesh Vijayan iD

FEBS Letters · 2026-07 · 600 (14) · 2012-2027

DOI: 10.1002/1873-3468.70308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, online erschienen am 24.02.2026. Verfasst von Ann Teres Babu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Thiruvananthapuram, India. Hauptthemen laut MEDLINE: alpha-Synuclein, DNA-Binding Proteins, RNA-Binding Proteins, Protein Aggregates. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Scheme for Transformational and Advanced Research in Sciences (STARS), Ministry of Education, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormal accumulation of misfolded proteins is a hallmark of neurodegenerative diseases. Amyloid aggregation of α‐synuclein (α‐Syn) and TAR DNA‐binding protein 43 (TDP‐43) contributes to Parkinson's disease and frontotemporal dementia, respectively. The heterotypic aggregates are increasingly recognized as highly cytotoxic. Given the frequent co‐occurrence of α‐Syn, TDP‐43, and tau pathologies, we examined whether the first prion‐like domain (PRD1) of CPEB3 modulates α‐Syn and TDP‐43 aggregation. Nuclear magnetic resonance (NMR) relaxation experiments revealed a direct interaction between PRD1 and the amyloid core of α‐Syn, suppressing its aggregation, while phase separation assays showed delayed liquid–liquid phase separation (LLPS) ‐mediated α‐Syn aggregation. In contrast, no interaction was detected with the C‐terminal domain of TDP‐43 (TDP‐43 CTD ), indicating selective inhibition of α‐Syn aggregation by PRD1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinDNA-Binding ProteinsRNA-Binding ProteinsProtein AggregatesProtein Aggregation, PathologicalHumansProtein DomainsProtein BindingPhase Separation

Stichwörter der Autor:innen

NMR spectroscopyParkinson's diseaseTDP‐43aggregation inhibitorphase separationprotein–protein interactionα‐synuclein

Substanzen

alpha-SynucleinDNA-Binding ProteinsTARDBP protein, humanRNA-Binding ProteinsProtein Aggregates

Autor:innen und Institutionen

  • School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Thiruvananthapuram, India.

ORCID-Profile: Vinesh Vijayan

Förderung

  • Scheme for Transformational and Advanced Research in Sciences (STARS), Ministry of Education, Government of India

Zitieren

APA

Babu, A. T., A, M. F., Periasamy, H. V., & Vijayan, V. (2026). CPEB3 selectively inhibits α‐synuclein aggregation without modulating TDP ‐43 pathology. FEBS Letters, 600(14), 2012-2027. https://doi.org/10.1002/1873-3468.70308

Vancouver

Babu AT, A MF, Periasamy HV, Vijayan V. CPEB3 selectively inhibits α‐synuclein aggregation without modulating TDP ‐43 pathology. FEBS Letters. 2026;600(14):2012-2027. doi:10.1002/1873-3468.70308

BibTeX
@article{Babu2026,
  author = {Babu, Ann Teres and A, Mufeeda Farhana and Periasamy, Harsha Varthini and Vijayan, Vinesh},
  title = {CPEB3 selectively inhibits α‐synuclein aggregation without modulating TDP ‐43 pathology},
  journal = {FEBS Letters},
  year = {2026},
  volume = {600},
  number = {14},
  pages = {2012--2027},
  doi = {10.1002/1873-3468.70308}
}
Kostenlos starten →